Ratings by Summer Street

Date CompanySymbol Type Rating
(Past)
Start $ End $ % Chg. Details
6/27/2014 Intercept Pharmaceuticals ICPT Maintain Buy
(N/A)
      Details
6/16/2014 Smith & Nephew SNN Maintain Buy
(N/A)
      Details
6/13/2014 Intercept Pharmaceuticals ICPT Maintain Buy
(N/A)
      Details
6/12/2014 BioDelivery Sciences International BDSI Maintain Buy
(N/A)
      Details
6/5/2014 Smith & Nephew SNN Maintain Buy
(N/A)
      Details
5/30/2014 BioDelivery Sciences International BDSI Maintain Buy
(N/A)
      Details
5/29/2014 Smith & Nephew SNN Maintain Buy
(N/A)
      Details
5/23/2014 ISIS Pharmaceuticals ISIS Maintain Neutral
(N/A)
      Details
5/21/2014 Intercept Pharmaceuticals ICPT Maintain Buy
(N/A)
      Details
5/20/2014 Intercept Pharmaceuticals ICPT Maintain Buy
(N/A)
      Details
5/19/2014 Zimmer Holdings ZMH Upgrade Buy
(Neutral)
100.61 102.22 1.6% Details
5/15/2014 BioDelivery Sciences International BDSI New Coverage Buy
(N/A)
8.43 13.42 59.19% Details
5/15/2014 Emergent BioSolutions EBS New Coverage Buy
(N/A)
21.01 22.63 7.71% Details
5/15/2014 Intercept Pharmaceuticals ICPT New Coverage Buy
(N/A)
270.94 240.55 -11.22% Details
5/14/2014 Durata Therapeutics DRTX Maintain Buy
(N/A)
      Details
5/7/2014 Tornier TRNX Upgrade Neutral
(Sell)
17.87 21.60 20.87% Details
4/30/2014 NuVasive NUVA Upgrade Buy
(Neutral)
33.92 38.22 12.68% Details
4/21/2014 Celgene CELG Maintain Buy
(N/A)
      Details
4/10/2014 Harvard Apparatus Regenerative Technology HART New Coverage Buy
(N/A)
8.87 7.73 -12.85% Details
4/9/2014 Durata Therapeutics DRTX New Coverage Buy
(N/A)
12.95 13.17 1.7% Details
4/9/2014 Flamel Technologies FLML New Coverage Buy
(N/A)
13.16 13.49 2.51% Details
4/7/2014 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
      Details
3/19/2014 Celgene CELG Maintain Buy
(N/A)
      Details
3/17/2014 Celgene CELG Maintain Buy
(N/A)
      Details
3/13/2014 Ligand Pharma LGND Maintain Buy
(N/A)
      Details
3/12/2014 Sunshine Heart SSH Maintain Buy
(N/A)
      Details
3/11/2014 Northwest Biotherapeutics NWBO Maintain Buy
(N/A)
      Details
3/10/2014 Northwest Biotherapeutics NWBO Maintain Buy
(N/A)
      Details
3/6/2014 Avanir Pharmaceuticals AVNR Maintain Buy
(N/A)
      Details
2/26/2014 Anika Therapeutics ANIK Maintain Buy
(N/A)
      Details
2/24/2014 Smith & Nephew SNN Maintain Buy
(N/A)
      Details
2/24/2014 Ligand Pharma LGND Maintain Buy
(N/A)
      Details
2/14/2014 CONMED CNMD Maintain Buy
(N/A)
      Details
2/13/2014 Rockwell Medical Technologies RMTI Maintain Buy
(N/A)
      Details
2/12/2014 Alphatec Holdings ATEC Maintain Buy
(N/A)
      Details
2/12/2014 Ligand Pharma LGND Maintain Buy
(N/A)
      Details
2/5/2014 Gilead Sciences GILD Maintain Neutral
(N/A)
      Details
1/27/2014 Ligand Pharma LGND Maintain Buy
(N/A)
      Details
1/23/2014 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
      Details
1/22/2014 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
      Details
1/7/2014 Rockwell Medical Technologies RMTI Maintain Buy
(N/A)
      Details
12/31/2013 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
      Details
12/19/2013 Vertex VRTX Maintain Neutral
(N/A)
      Details
12/17/2013 Rockwell Medical Technologies RMTI Maintain Buy
(N/A)
      Details
12/12/2013 ImmunoCellular Therapeutics IMUC Maintain Buy
(N/A)
      Details
12/11/2013 Avanir Pharmaceuticals AVNR Maintain Buy
(N/A)
      Details
12/10/2013 ARIAD Pharmaceuticals ARIA Maintain Neutral
(N/A)
      Details
12/9/2013 Smith & Nephew SNN Maintain Buy
(N/A)
      Details
12/2/2013 Sunshine Heart SSH Maintain Buy
(N/A)
      Details
11/27/2013 NPS Pharmaceuticals Inc. NPSP Maintain Buy
(N/A)
      Details
11/22/2013 Ligand Pharma LGND Maintain Buy
(N/A)
      Details
11/6/2013 Tornier TRNX Downgrade Sell
(Buy)
21.16 17.87 -15.55% Details
11/1/2013 Anika Therapeutics ANIK Maintain Buy
(N/A)
      Details
10/31/2013 ARIAD Pharmaceuticals ARIA Maintain Neutral
(N/A)
      Details
10/30/2013 Vertex VRTX Downgrade Neutral
(Buy)
76.09 92.01 20.92% Details
10/24/2013 AMAG Pharmaceuticals AMAG Maintain Buy
(N/A)
      Details
10/10/2013 ARIAD Pharmaceuticals ARIA Downgrade Neutral
(Buy)
5.83 6.12 4.97% Details
9/26/2013 MAKO Surgical MAKO Downgrade Neutral
(Buy)
29.46 29.99 1.8% Details
9/19/2013 Northwest Biotherapeutics NWBO New Coverage Buy
(N/A)
3.41 6.92 102.93% Details
9/5/2013 Rockwell Medical Technologies RMTI Maintain Buy
(N/A)
      Details
8/26/2013 Onyx Pharmaceuticals ONXX Downgrade Neutral
(Buy)
116.96 124.70 6.62% Details
5/30/2013 Wright Medical WMGI Upgrade Buy
(Neutral)
24.23 31.45 29.8% Details
4/30/2013 Conceptus CPTS Downgrade Neutral
(Buy)
30.96 31.02 0.19% Details
3/6/2013 Conceptus CPTS Upgrade Buy
(Neutral)
22.66 30.96 36.63% Details
2/20/2013 BioMimetic Therapeutics BMTI Downgrade Neutral
(Buy)
8.85 9.49 7.23% Details
1/30/2013 Zimmer Holdings ZMH Downgrade Neutral
(Buy)
75.42 100.61 33.4% Details
1/24/2013 Dendreon DNDN Maintain Buy
(N/A)
      Details
11/20/2012 Endocyte ECYT New Coverage Buy
(N/A)
7.75 7.10 -8.39% Details
11/15/2012 Puma Biotechnology PBYI Downgrade Neutral
(Buy)
16.50 224.49 1260.55% Details
11/6/2012 BioMarin Pharmaceutical Inc. BMRN Maintain Buy
(N/A)
      Details
11/5/2012 MAKO Surgical MAKO Upgrade Buy
(Neutral)
15.40 29.46 91.3% Details
10/17/2012 ISIS Pharmaceuticals ISIS Downgrade Neutral
(Buy)
10.27 31.88 210.42% Details
10/4/2012 NuVasive NUVA Downgrade Neutral
(Buy)
14.97 33.92 126.59% Details
7/27/2012 AMAG Pharmaceuticals AMAG Upgrade Buy
(Neutral)
15.25 19.54 28.13% Details
7/17/2012 Human Genome Sciences HGSI Downgrade Neutral
(Buy)
14.19 14.24 0.35% Details
7/10/2012 MAKO Surgical MAKO Downgrade Neutral
(Buy)
14.73 15.40 4.55% Details
6/13/2012 Dendreon DNDN New Coverage Buy
(N/A)
6.25 2.10 -66.4% Details
5/8/2012 Vertex VRTX Maintain Buy
(N/A)
      Details
4/11/2012 Rockwell Medical Technologies RMTI New Coverage Buy
(N/A)
8.85 10.43 17.85% Details
4/3/2012 Æterna Zentaris AEZS Downgrade Neutral
(N/A)
0.73 1.18 61.64% Details
3/22/2012 Synergy Pharmaceuticals SGYP New Coverage Buy
(N/A)
4.15 3.78 -8.92% Details
3/7/2012 MAKO Surgical MAKO Maintain Buy
(N/A)
      Details
3/2/2012 Anthera Pharma ANTH New Coverage Buy
(N/A)
6.46 2.93 -54.64% Details
1/30/2012 Amylin Pharmaceuticals AMLN Downgrade Neutral
(N/A)
12.14 30.98 155.19% Details
1/13/2012 Ligand Pharma LGND New Coverage Buy
(N/A)
11.97 51.17 327.49% Details
1/3/2012 MAKO Surgical MAKO Upgrade Buy
(N/A)
25.21 14.73 -41.57% Details
12/13/2011 Avanir Pharmaceuticals AVNR Maintain Buy
(N/A)
      Details
11/22/2011 Gilead Sciences GILD Downgrade Neutral
(N/A)
36.26 93.79 158.66% Details
10/25/2011 Adolor ADLR Downgrade Neutral
(N/A)
4.67 4.77 2.14% Details
10/18/2011 Medivation MDVN New Coverage Buy
(N/A)
8.21 76.25 828.75% Details
10/6/2011 Curis CRIS New Coverage Buy
(N/A)
3.26 1.88 -42.33% Details
10/5/2011 Seattle Genetics SGEN New Coverage Sell
(N/A)
20.34 35.89 76.45% Details
9/19/2011 MAKO Surgical MAKO New Coverage Neutral
(N/A)
36.27 25.21 -30.49% Details
9/19/2011 Alphatec Holdings ATEC New Coverage Buy
(N/A)
2.60 1.42 -45.38% Details
9/19/2011 BioMimetic Therapeutics BMTI New Coverage Buy
(N/A)
4.04 8.85 119.06% Details
9/19/2011 TranS1 Inc TSON New Coverage Buy
(N/A)
3.70 2.06 -44.32% Details
9/19/2011 Tornier TRNX New Coverage Buy
(N/A)
21.69 21.16 -2.44% Details
9/19/2011 Anika Therapeutics ANIK New Coverage Buy
(N/A)
5.74 49.75 766.72% Details
9/19/2011 NuVasive NUVA New Coverage Buy
(N/A)
22.13 22.62 2.21% Details
8/31/2011 Immunomedics IMMU New Coverage Buy
(N/A)
3.98 3.42 -14.07% Details
8/25/2011 ARIAD Pharmaceuticals ARIA New Coverage Buy
(N/A)
8.83 5.83 -33.98% Details
8/23/2011 Onyx Pharmaceuticals ONXX New Coverage Buy
(N/A)
29.76 116.96 293.01% Details
8/2/2011 Conceptus CPTS New Coverage Neutral
(N/A)
11.21 22.66 102.14% Details
7/21/2011 AMAG Pharmaceuticals AMAG Downgrade Neutral
(N/A)
16.24 15.25 -6.1% Details
7/18/2011 Adolor ADLR New Coverage Buy
(N/A)
2.43 4.67 92.18% Details
5/4/2011 Æterna Zentaris AEZS New Coverage Buy
(N/A)
2.24 0.73 -67.41% Details
3/14/2011 AMAG Pharmaceuticals AMAG Upgrade Buy
(N/A)
16.89 19.07 12.91% Details
1/19/2011 Exactech Inc EXAC New Coverage Buy
(N/A)
17.01 23.05 35.51% Details
12/23/2010 Arena Pharma ARNA Upgrade Neutral
(N/A)
1.80 4.77 165% Details
9/29/2010 ViroPharma VPHM New Coverage Neutral
(N/A)
15.22 49.96 228.25% Details
9/15/2010 Arena Pharma ARNA Downgrade Sell
(N/A)
4.13 1.80 -56.42% Details